Physician profile
Pooja Handa
NPI 1508022955
$842.82
in general payments reported to CMS, 2019-2025
13 companies · $645 in 2025
The $645 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $15.14 · 2024: $183 · 2025: $645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $843.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $842.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tempus Ai, INC | $224.89 | 2025 | Xt Cdx |
| Astrazeneca Pharmaceuticals LP | $128.05 | 2024-2025 | Airsupra, Farxiga, Breztri |
| Exact Sciences Corporation | $102.94 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $85.85 | 2025 | Trelegy Ellipta, Arexvy |
| Dynavax Technologies Corporation | $78.67 | 2025 | Heplisav-B |
| Lilly USA, LLC | $58.78 | 2025 | Zepbound, Mounjaro, Jardiance |
| Sanofi-Aventis U.S. LLC | $47.42 | 2024 | |
| Pfizer INC. | $25.00 | 2024 | |
| Abbott Laboratories | $23.64 | 2025 | Freestyle Libre 3 |
| Xeris Pharmaceuticals, INC. | $18.93 | 2025 | Gvoke Hypopen |
| Hologic Sales and Service, LLC | $16.42 | 2025 | Aptima |
| Azurity Pharmaceuticals, INC. | $16.41 | 2025 | Horizant |
| Otsuka America Pharmaceutical, INC. | $15.82 | 2024 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pooja Handa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.